Zobrazeno 1 - 10
of 28
pro vyhledávání: '"H.-M. Reinold"'
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 113:1801-1805
An open lung biopsy in a 67-year-old man revealed nocardiosis as the cause of a treatment-resistant pulmonary infection. His resistance had been weakened by a non-Hodgkin lymphoma, polychemotherapy and long-term steroid medication. The nocardiosis wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f0e3bc258eaa200b328a5b20ec1dc00
https://doi.org/10.1055/s-2008-1067891
https://doi.org/10.1055/s-2008-1067891
Autor:
M. Freund, M. Lutz, J.Th. Fischer, T. Zwingers, H.-M. Reinold, B. Steinke, T. Hecht, H. Arnold, C. Manegold, Eva Lengfelder, A. Münz
Publikováno v:
Oncology Research and Treatment. 17:248-253
Background: Hematologic growth factors may allow dose intensification of chemotherapy, possibly leading to improved treatment results in high-grade malignant non-Hodgkin’s lymphomas. In the present st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36090c750cb7155fdc17fe5efaf8d4d5
https://doi.org/10.1159/000218421
https://doi.org/10.1159/000218421
Autor:
R. Leo, B. R. Suchy, J. Oertel, J. Währisch, Helmuth Deicher, M. Planker, C.-H.-R. Hauswaldt, K. Görg, A. Georgii, C. Tirier, H. Gamm, J. Karow, K. Schumacher, M. Sailer, H.J. Keyserlingk, R. Coldewey, M. Gramatzki, D. Peest, Volker Diehl, H. M. Reinold, A. Kindler, V. Hiemeyer, U. Essers, E. Schäfer, C. Vykoupil, E. Hoeppner, S. Glück, D. Urbanitz, E. Heilmann
Publikováno v:
European Journal of Cancer. 29:978-983
Follow-up data of 320 multiple myeloma (MM) patients entering the German Myeloma Treatment Group (GMTG) trial MM01 were analysed for factors predicting overall (OAS) and tumour related survival (TRS). Response to primary induction chemotherapy was re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d03ccf0bd6b2ba9c148f3fdcc3cd664a
https://doi.org/10.1016/s0959-8049(05)80205-9
https://doi.org/10.1016/s0959-8049(05)80205-9
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP
Autor:
K.P. Schalk, H.K. Müller-Hermelink, H. Arnold, B. Steinke, H.-M. Reinold, K. Josten, Th. Zwingers, M.E. Heim, A.C. Feller, K. Bross, E. Heidemann, C. Manegold, I. Hoffman
Publikováno v:
European Journal of Cancer. 28:100-104
Between 1986 and 1988, 81 patients with high grade malignant non-Hodgkin lymphoma according to the Kiel classification were treated with the VIM-Bleo/CHOP-regimen: etoposide 100 mg/m2 intravenously on days 1-3, ifosfamide 1.5 g/m2 intravenously days
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613a168c8ad4d0cce9ef141fabae2c25
https://doi.org/10.1016/0959-8049(92)90395-i
https://doi.org/10.1016/0959-8049(92)90395-i
Autor:
T. Hecht, T. Zwingers, J.Th. Fischer, A. Münz, M. Lutz, H.-M. Reinold, M. Freund, C. Manegold, H. Arnold, B. Steinke, Eva Lengfelder
Publikováno v:
Oncology Research and Treatment. 15:46-50
Background: Hematologic growth factors may allow those intensification of chemotherapy possibly leading to an improvement of treatment results in high grade malignant non-Hodgkin’s lymphomas. In the present study the possibility of reducing the tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64bee4dc5ea8f506372b6d80a5d946ea
https://doi.org/10.1159/000217332
https://doi.org/10.1159/000217332
Autor:
L. Edler, P.M. Schlag, G. Leppien, W.U. Knauf, H. Kriegbaum, E. Lengfelder, W.E. Berdel, T. Zwingers, H.-M. Reinold, W. Queißer, R. Herrmann, P.A. Palmer, H.H. Fiebig, F. Porzsolt, K. Pohlodek, E. Späth-Schwalbe, H.J. Senn, J.Th. Fischer, M. Hünerbein, J. Richner, H. Gallati, T. Hecht, R. Morant, P. Drings, B. Reufi, R. Becher, H. Sindermann, H. Arnold, C.A. Papadimitriou, G. Stohlmann, M. Aapro, K. Bremer, I. Funke, B. Rau, H. Schmid, B.M. Frey, E. Thiel, D. Oberberg, C. Manegold, A.-R. Hanauske, M. Lutz, A. Harstrick, M. Koenigsmann, E. Oelmann, H. Schrezenmeier, A. Gescher, W. Rauschning, S. Kerpel-Fronius, C. Bokemeyer, B. Steinke, M. Kaufmann, A. Münz, O. Prümmer, W.F. Riesen, H.-J. Schmoll, M. Freund
Publikováno v:
Oncology Research and Treatment. 17:291-293
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3014af737d2c4f6ca435dafc9ab7a073
https://doi.org/10.1159/000218429
https://doi.org/10.1159/000218429
Publikováno v:
Erkrankungen endokriner Organe: Klinik, Diagnostik und Differenzialtherapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9989f8359e88e5a918f7b015b2e9b01d
https://doi.org/10.1055/b-001-3192
https://doi.org/10.1055/b-001-3192
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 110:1855-1856
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2c80cd591f6dd58354052e8709b2697
https://doi.org/10.1055/s-2008-1069102
https://doi.org/10.1055/s-2008-1069102
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 100:2277-2282
Generalized lymphangiomyomatosis with diffuse pulmonary involvement was diagnosed at post-mortem of a 26-year-old woman. The disease occurs only in women, during or after their reproductive phase, with chylous effusion, especially chylothorax, dyspno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a5360adfb2fa05f1f319b119f4b8e0e
https://doi.org/10.1055/s-0028-1106535
https://doi.org/10.1055/s-0028-1106535
Publikováno v:
Pharmacologia Clinica. 1:114-118
3H-ouabain was administered intravenously to control patients, and to patients suffering from liver disease or renal failure. In the control patients the 3H-ouabain disappeared from the serum by two exponentials, with half-lives of about 20 min and 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bda936b558e4d7373712e1e423d04d9b
https://doi.org/10.1007/bf00404656
https://doi.org/10.1007/bf00404656